Advertisement

PharmacoEconomics & Outcomes News

, Volume 818, Issue 1, pp 38–38 | Cite as

NICE recommends nivolumab for resected stage III and IV melanoma

News item
  • 7 Downloads

Reference

  1. NICE. Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease Internet Document : Nov 2018. Available from: URL: https://www.nice.org.uk/guidance/gid-ta10286/documents/final-appraisal-determination-documentGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations